Skip to main content
Erschienen in: World Journal of Surgery 7/2013

01.07.2013

The Role of Unilateral Adrenalectomy in Corticotropin-Independent Bilateral Adrenocortical Hyperplasias

verfasst von: Yunze Xu, Wenbin Rui, Yicheng Qi, Chongyu Zhang, Juping Zhao, Xiaojing Wang, Yuxuan Wu, Qi Zhu, Zhoujun Shen, Guang Ning, Yu Zhu

Erschienen in: World Journal of Surgery | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of the present study was twofold: to demonstrate our experience with unilateral adrenalectomy in the treatment of adrenocorticotropic hormone (ACTH)-independent Cushing syndrome (CS) caused by bilateral adrenocortical hyperplasias, and to evaluate the long-term results as evidenced by the main laboratory and clinical findings.

Methods

From February 2000 to August 2009, unilateral adrenalectomy was performed on 27 patients with ACTH-independent CS and bilateral adrenocortical hyperplasias, including 14 patients with ACTH-independent macronodular adrenal hyperplasia (AIMAH) and 13 patients with primary pigmented nodular adrenocortical disease (PPNAD). Signs and symptoms of CS, endocrine examinations, and radiographic imaging were evaluated preoperatively and postoperatively.

Results

At a median follow-up of 69 months (range: 23–120 months) for AIMAH and 47 months (range: 16–113 months) for PPNAD, 25 patients were cured by unilateral adrenalectomy. Serum cortisol level, daily urinary free cortisol (UFC), and plasma ACTH regained the normal range in both AIMAH and PPNAD patients at monthly follow-up visits; the circadian serum cortisol rhythm returned to normal, and a normal responsiveness to overnight low-dose dexamethasone administration (LDDST) became obvious. Both systolic and diastolic blood pressure (BP) levels were significantly reduced: 85 % of patients recovered normal BP levels, and the remaining patients need antihypertensive drugs, but at a reduced dose. No surgery-related morbidity occurred, and there was no sign of further enlargement of the residual adrenal gland after successful unilateral adrenalectomy. One patient with PPNAD and another patient with AIMAH with similar weights and sizes of the bilateral adrenals needed contralateral adrenalectomy.

Conclusions

Unilateral adrenalectomy may be the suitable treatment for selected patients with AIMAH and PPNAD. It can achieve long-term remission of CS and improve glycemic control and BP values.
Literatur
1.
Zurück zum Zitat Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441–458 xPubMedCrossRef Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441–458 xPubMedCrossRef
3.
Zurück zum Zitat Stratakis CA, Kirschner LS (1998) Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30:456–463PubMedCrossRef Stratakis CA, Kirschner LS (1998) Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30:456–463PubMedCrossRef
4.
Zurück zum Zitat Lamas C, Alfaro JJ, Lucas T et al (2002) Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: long-term follow-up of four cases. Eur J Endocrinol 146:237–240PubMedCrossRef Lamas C, Alfaro JJ, Lucas T et al (2002) Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: long-term follow-up of four cases. Eur J Endocrinol 146:237–240PubMedCrossRef
5.
Zurück zum Zitat Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602PubMedCrossRef Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602PubMedCrossRef
6.
Zurück zum Zitat Bertagna X, Guignat L, Groussin L et al (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623PubMedCrossRef Bertagna X, Guignat L, Groussin L et al (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623PubMedCrossRef
7.
Zurück zum Zitat Ilias I, Torpy DJ, Pacak K et al (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955–4962PubMedCrossRef Ilias I, Torpy DJ, Pacak K et al (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955–4962PubMedCrossRef
8.
Zurück zum Zitat Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526–1540PubMedCrossRef Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526–1540PubMedCrossRef
9.
Zurück zum Zitat Gunther DF, Bourdeau I, Matyakhina L et al (2004) Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89:3173–3182PubMedCrossRef Gunther DF, Bourdeau I, Matyakhina L et al (2004) Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89:3173–3182PubMedCrossRef
10.
Zurück zum Zitat Kirschner MA, Powell RD Jr, Lipsett MB (1964) Cushing’s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 24:947–955PubMedCrossRef Kirschner MA, Powell RD Jr, Lipsett MB (1964) Cushing’s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 24:947–955PubMedCrossRef
11.
Zurück zum Zitat Aiba M, Hirayama A, Iri H et al (1991) Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing’s syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol 96:334–340PubMed Aiba M, Hirayama A, Iri H et al (1991) Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing’s syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol 96:334–340PubMed
12.
Zurück zum Zitat Lacroix A, Ndiaye N, Tremblay J et al (2001) Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev 22:75–110PubMedCrossRef Lacroix A, Ndiaye N, Tremblay J et al (2001) Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev 22:75–110PubMedCrossRef
13.
Zurück zum Zitat Zeiger MA, Nieman LK, Cutler GB et al (1991) Primary bilateral adrenocortical causes of Cushing’s syndrome. Surgery 110:1106–1115PubMed Zeiger MA, Nieman LK, Cutler GB et al (1991) Primary bilateral adrenocortical causes of Cushing’s syndrome. Surgery 110:1106–1115PubMed
14.
Zurück zum Zitat Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041–4046PubMedCrossRef Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041–4046PubMedCrossRef
15.
Zurück zum Zitat Goodarzi MO, Dawson DW, Li X et al (2003) Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. J Clin Endocrinol Metab 88:73–77PubMedCrossRef Goodarzi MO, Dawson DW, Li X et al (2003) Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. J Clin Endocrinol Metab 88:73–77PubMedCrossRef
16.
Zurück zum Zitat Lacroix A (2009) ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:245–259PubMedCrossRef Lacroix A (2009) ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:245–259PubMedCrossRef
17.
Zurück zum Zitat Doppman JL, Nieman LK, Travis WD et al (1991) CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. J Comput Assist Tomogr 15:773–779PubMedCrossRef Doppman JL, Nieman LK, Travis WD et al (1991) CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. J Comput Assist Tomogr 15:773–779PubMedCrossRef
18.
Zurück zum Zitat Doppman JL, Chrousos GP, Papanicolaou DA et al (2000) Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216:797–802PubMed Doppman JL, Chrousos GP, Papanicolaou DA et al (2000) Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216:797–802PubMed
19.
Zurück zum Zitat Newell-Price J, Bertagna X, Grossman AB et al (2006) Cushing’s syndrome. Lancet 367:1605–1617PubMedCrossRef Newell-Price J, Bertagna X, Grossman AB et al (2006) Cushing’s syndrome. Lancet 367:1605–1617PubMedCrossRef
20.
Zurück zum Zitat Doppman JL, Travis WD, Nieman L et al (1989) Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 172:415–420PubMed Doppman JL, Travis WD, Nieman L et al (1989) Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 172:415–420PubMed
21.
Zurück zum Zitat Sahdev A, Reznek RH, Evanson J et al (2007) Imaging in Cushing’s syndrome. Arq Bras Endocrinol Metab 51:1319–1328CrossRef Sahdev A, Reznek RH, Evanson J et al (2007) Imaging in Cushing’s syndrome. Arq Bras Endocrinol Metab 51:1319–1328CrossRef
22.
Zurück zum Zitat Shen WT, Lee J, Kebebew E et al (2006) Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg 141:771–774 discussion 774–776PubMedCrossRef Shen WT, Lee J, Kebebew E et al (2006) Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg 141:771–774 discussion 774–776PubMedCrossRef
23.
Zurück zum Zitat Storr HL, Mitchell H, Swords FM et al (2004) Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 61:553–559CrossRef Storr HL, Mitchell H, Swords FM et al (2004) Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 61:553–559CrossRef
24.
Zurück zum Zitat Sato M, Soma M, Nakayama T et al (2006) A case of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) with primary hyperparathyroidism (PHPT). Endocr J 53:111–117PubMedCrossRef Sato M, Soma M, Nakayama T et al (2006) A case of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) with primary hyperparathyroidism (PHPT). Endocr J 53:111–117PubMedCrossRef
25.
Zurück zum Zitat Vezzosi D, Cartier D, Regnier C et al (2007) Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 156:21–31PubMedCrossRef Vezzosi D, Cartier D, Regnier C et al (2007) Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 156:21–31PubMedCrossRef
Metadaten
Titel
The Role of Unilateral Adrenalectomy in Corticotropin-Independent Bilateral Adrenocortical Hyperplasias
verfasst von
Yunze Xu
Wenbin Rui
Yicheng Qi
Chongyu Zhang
Juping Zhao
Xiaojing Wang
Yuxuan Wu
Qi Zhu
Zhoujun Shen
Guang Ning
Yu Zhu
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2059-9

Weitere Artikel der Ausgabe 7/2013

World Journal of Surgery 7/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.